|
|
Previous Article | Table of Contents | Next Article 
Long-term culture of chronic myelogenous leukemia marrow cells on stem cell
factor-deficient stroma favors benign progenitors
R Agarwal, S Doren, B Hicks and CE Dunbar
Children's Hospital Medical Center, Cincinnati, OH.
Long-term culture of marrow from patients with chronic myelogenous leukemia
(CML) has been reported to favor the outgrowth of bcr/abl- progenitor cells
in some patients. We examined the effect of the presence of soluble or
transmembrane forms of stem cell factor (SCF) in long-term cultures of CML
marrow. CD34-enriched cells from CML patients in advanced chronic phase or
accelerated phase were plated on immortalized fetal liver stromal cells
from homozygous SCF-deficient SI/SI mice (SI/SI4) with or without the
addition of soluble human SCF, SI/SI4 cells expressing high levels of the
transmembrane form of human SCF (SI/SIh220), or primary human allogeneic
stroma. Cells were removed from cultures and plated weekly in colony
assays. The clonagenic cell output from cultures completely lacking SCF was
lower over the first 2 to 3 weeks, but by 5 weeks was similar to the
clonagenic cell output from the other culture conditions. Analysis of
bcr/abl transcripts from individual colonies showed a lower percentage of
malignant progenitors present in long-term cultures completely deficient in
SCF than under the other culture conditions, particularly compared with
primary human stroma-containing long-term cultures. SCF may specifically
favor malignant versus benign progenitor cells present in the marrow of CML
patients, and an abnormal proliferative response to SCF in very primitive
cells may be an underlying defect in the pathophysiology of this disease.
Volume 85,
Issue 5,
pp. 1306-1312,
03/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. N. Savani, K. Rezvani, S. Mielke, A. Montero, R. Kurlander, C. S. Carter, S. Leitman, E. J. Read, R. Childs, and A. J. Barrett
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
Blood,
February 15, 2006;
107(4):
1688 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Childs, E. Clave, N. Contentin, D. Jayasekera, N. Hensel, S. Leitman, E.J. Read, C. Carter, E. Bahceci, N.S. Young, et al.
Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses
Blood,
November 1, 1999;
94(9):
3234 - 3241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Moore, D. N. Haylock, J.-P. Levesque, L. A. McDiarmid, L. M. Samels, L. B. To, P. J. Simmons, and T. P. Hughes
Stem Cell Factor as a Single Agent Induces Selective Proliferation of the Philadelphia Chromosome Positive Fraction of Chronic Myeloid Leukemia CD34+ Cells
Blood,
October 1, 1998;
92(7):
2461 - 2470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O'Prey, N. Leslie, K. Itoh, W. Ostertag, C. Bartholomew, and P. R. Harrison
Both Stroma and Stem Cell Factor Maintain Long-Term Growth of ELM Erythroleukemia Cells, but Only Stroma Prevents Erythroid Differentiation in Response to Erythropoietin and Interleukin-3
Blood,
March 1, 1998;
91(5):
1548 - 1555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Lewis, L. A. McDiarmid, L. M. Samels, L. Bik To, and T. P. Hughes
Establishment of a Reproducible Model of Chronic-Phase Chronic Myeloid Leukemia in NOD/SCID Mice Using Blood-Derived Mononuclear or CD34+ Cells
Blood,
January 15, 1998;
91(2):
630 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bhatia, C. M. Verfaillie, J. S. Miller, and P. B. McGlave
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
Blood,
April 15, 1997;
89(8):
2623 - 2634.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Crystal
Transfer of Genes to Humans: Early Lessons and Obstacles to Success
Science,
October 20, 1995;
270(5235):
404 - 410.
[Abstract]
[PDF]
|
 |
|
|
|